Mural Oncology (MURA) Income Statement Analysis - Revenue, Earnings & Profitability Metrics - Stocknear

Mural Oncology

NASDAQ: MURA · Real-Time Price · USD
2.07
0.00 (0.00%)
At close: Sep 05, 2025, 3:59 PM
2.07
0.00%
After-hours: Sep 05, 2025, 05:48 PM EDT

Mural Oncology Income Statement

Financials in USD. Fiscal year is undefined.
Fiscal Year FY 2024 FY 2023 FY 2022 FY 2021
Period Ending Dec 31, 2024 Dec 31, 2023 Dec 31, 2022 Dec 31, 2021
Revenue
n/a n/a n/a n/a
Cost of Revenue
3.51M 2.57M 1.54M 1.47M
Gross Profit
-3.51M -2.57M -1.54M -1.47M
Operating Income
-138.26M -194.64M -184.92M -175.37M
Interest Income
9.75M n/a n/a n/a
Pretax Income
-128.51M -195.29M -184.92M -175.37M
Net Income
-128.51M -207.45M -200.03M -175.43M
Selling & General & Admin
27.6M 30.04M 25.08M 15.55M
Research & Development
110.67M 162.03M 170.07M 159.82M
Other Expenses
-3.51M n/a n/a -1.47M
Operating Expenses
134.75M 192.07M 195.15M 173.89M
Interest Expense
n/a n/a n/a n/a
Selling & Marketing Expenses
n/a -667K n/a n/a
Cost & Expenses
138.26M 194.64M 184.92M 175.37M
Income Tax Expense
n/a 12.16M 4.88M 68K
Shares Outstanding (Basic)
16.95M 16.69M 16.69M 16.69M
Shares Outstanding (Diluted)
16.95M 16.69M 16.69M 16.69M
EPS (Basic)
-7.58 -12.43 -11.37 -10.51
EPS (Diluted)
-7.58 -12.43 -11.37 -10.51
EBITDA
-125M -192.72M -183.38M -173.89M
EBIT
-128.51M -195.29M -184.92M -175.37M
Depreciation & Amortization
3.51M 2.57M 1.54M 1.47M